ROSCIGNO, GIUSEPPINA
ROSCIGNO, GIUSEPPINA
Istituto degli Endotipi in Oncologia, Metabolismo e Immunologia "G. Salvatore" (IEOMI)
Selection of RNA aptamers targeting hypoxia in cancer
2022 Nuzzo, S.; Iaboni, M.; Ibba, M. L.; Rienzo, A.; Musumeci, D.; Franzese, M.; Roscigno, G.; Affinito, A.; Petrillo, G.; Quintavalle, C.; Ciccone, G.; Esposito, C. L.; Catuogno, S.
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy
2021 Esposito, C. L.; Quintavalle, C.; Ingenito, F.; Rotoli, D.; Roscigno, G.; Nuzzo, S.; Thomas, R.; Catuogno, S.; Minic, Z.; Berezovski, M.; de Franciscis, V.; Condorelli, G.
MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment
2020 Roscigno, G; Cirella, A; Affinito, A; Quintavalle, C; Scognamiglio, I; Palma, F; Ingenito, F; Nuzzo, S; De Micco, F; Cuccuru, A; Thomas, R; Condorelli, G
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer
2020 Palma, F; Affinito, A; Nuzzo, S; Roscigno, G; Scognamiglio, I; Ingenito, F; Martinez, L; Franzese, M; Zanfardino, M; Soricelli, A; Fiorelli, A; Condorelli, G; Quintavalle, C
Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine
2019 Scialabba C.; Sciortino A.; Messina F.; Buscarino G.; Cannas M.; Roscigno G.; Condorelli G.; Cavallaro G.; Giammona G.; Mauro N.
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
2019 Affinito, A; Quintavalle, C; Esposito, Cl; Roscigno, G; Vilardo, C; Nuzzo, S; Vitiani, Lr; De Luca, G; Pallini, R; Kichkailo, As; Lapin, In; de Franciscis, V; Condorelli, G
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications
2019 Ingenito, F; Roscigno, G; Affnito, A; Nuzzo, S; Scognamiglio, I; Quintavalle, C; Condorelli, G
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
2018 Russo, V; Paciocco, A; Affinito, A; Roscigno, G; Fiore, D; Palma, F; Galasso, M; Volinia, S; Fiorelli, A; Esposito, Cl; Nuzzo, S; Inghirami, G; de Franciscis, V; Condorelli, G
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study
2018 Ng C.K.Y.; Di Costanzo G.G.; Tosti N.; Paradiso V.; CotoLlerena M.; Roscigno G.; Perrina V.; Quintavalle C.; Boldanova T.; Wieland S.; MarinoMarsilia G.; Lanzafame M.; Quagliata L.; Condorelli G.; Matter M.S.; Tortora R.; Heim M.H.; Terracciano L.M.; Piscuoglio S.
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
2017 Roscigno G.; Puoti I.; Giordano I.; Donnarumma E.; Russo V.; Affinito A.; Adamo A.; Quintavalle C.; Todaro M.; Vivanco M.D.; Condorelli G.
RYK promotes the stemness of glioblastoma cells via the WNT/?-catenin pathway
2017 Adamo, A; Fiore, D; De Martino, F; Roscigno, G; Affinito, A; Donnarumma, E; Puoti, I; Vitiani, Lr; Pallini, R; Quintavalle, C; Condorelli, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Selection of RNA aptamers targeting hypoxia in cancer | 1-gen-2022 | Nuzzo, S.; Iaboni, M.; Ibba, M. L.; Rienzo, A.; Musumeci, D.; Franzese, M.; Roscigno, G.; Affinito, A.; Petrillo, G.; Quintavalle, C.; Ciccone, G.; Esposito, C. L.; Catuogno, S. | |
| Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy | 1-gen-2021 | Esposito, C. L.; Quintavalle, C.; Ingenito, F.; Rotoli, D.; Roscigno, G.; Nuzzo, S.; Thomas, R.; Catuogno, S.; Minic, Z.; Berezovski, M.; de Franciscis, V.; Condorelli, G. | |
| MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment | 1-gen-2020 | Roscigno, G; Cirella, A; Affinito, A; Quintavalle, C; Scognamiglio, I; Palma, F; Ingenito, F; Nuzzo, S; De Micco, F; Cuccuru, A; Thomas, R; Condorelli, G | |
| miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer | 1-gen-2020 | Palma, F; Affinito, A; Nuzzo, S; Roscigno, G; Scognamiglio, I; Ingenito, F; Martinez, L; Franzese, M; Zanfardino, M; Soricelli, A; Fiorelli, A; Condorelli, G; Quintavalle, C | |
| Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine | 1-gen-2019 | Scialabba C.; Sciortino A.; Messina F.; Buscarino G.; Cannas M.; Roscigno G.; Condorelli G.; Cavallaro G.; Giammona G.; Mauro N. | |
| The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells | 1-gen-2019 | Affinito, A; Quintavalle, C; Esposito, Cl; Roscigno, G; Vilardo, C; Nuzzo, S; Vitiani, Lr; De Luca, G; Pallini, R; Kichkailo, As; Lapin, In; de Franciscis, V; Condorelli, G | |
| The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications | 1-gen-2019 | Ingenito, F; Roscigno, G; Affnito, A; Nuzzo, S; Scognamiglio, I; Quintavalle, C; Condorelli, G | |
| Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells | 1-gen-2018 | Russo, V; Paciocco, A; Affinito, A; Roscigno, G; Fiore, D; Palma, F; Galasso, M; Volinia, S; Fiorelli, A; Esposito, Cl; Nuzzo, S; Inghirami, G; de Franciscis, V; Condorelli, G | |
| Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study | 1-gen-2018 | Ng C.K.Y.; Di Costanzo G.G.; Tosti N.; Paradiso V.; CotoLlerena M.; Roscigno G.; Perrina V.; Quintavalle C.; Boldanova T.; Wieland S.; MarinoMarsilia G.; Lanzafame M.; Quagliata L.; Condorelli G.; Matter M.S.; Tortora R.; Heim M.H.; Terracciano L.M.; Piscuoglio S. | |
| MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer | 1-gen-2017 | Roscigno G.; Puoti I.; Giordano I.; Donnarumma E.; Russo V.; Affinito A.; Adamo A.; Quintavalle C.; Todaro M.; Vivanco M.D.; Condorelli G. | |
| RYK promotes the stemness of glioblastoma cells via the WNT/?-catenin pathway | 1-gen-2017 | Adamo, A; Fiore, D; De Martino, F; Roscigno, G; Affinito, A; Donnarumma, E; Puoti, I; Vitiani, Lr; Pallini, R; Quintavalle, C; Condorelli, G |